As at Jul 17, 2025, the TMDX stock has a PE ratio of 76.54. This is based on the current EPS of $1.47 and the stock price of $112.52 per share. A decrease of 86% has been recorded in the P/E ratio compared to the average of 536.3 of the last 4 quarters.
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
2024 | 58.27 | N/A | $62.35 | $1.07 |
2023 | N/A | N/A | $78.93 | -$0.77 |
2022 | N/A | N/A | $61.72 | -$1.23 |
2021 | N/A | N/A | $19.16 | -$1.6 |
2020 | N/A | N/A | $19.9 | -$1.16 |
2019 | N/A | N/A | $18.59 | -$2.36 |
2018 | N/A | N/A | N/A | -$17.48 |
2017 | N/A | N/A | N/A | -$4.48 |
2016 | N/A | N/A | N/A | -$5.35 |
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
Mar 2025 | 45.77 | -21.45% | $67.28 | $1.47 |
Dec 2024 | 58.27 | -63.26% | $62.35 | $1.07 |
Sep 2024 | 158.59 | -91.58% | $157 | $0.99 |
Jun 2024 | 1,882.75 | N/A | $150.62 | $0.08 |
Mar 2024 | N/A | N/A | $73.94 | -$0.32 |
Dec 2023 | N/A | N/A | $78.93 | -$0.77 |
Sep 2023 | N/A | N/A | $54.75 | -$1.09 |
Jun 2023 | N/A | N/A | $83.98 | -$0.56 |
Mar 2023 | N/A | N/A | $75.73 | -$0.94 |
Dec 2022 | N/A | N/A | $61.72 | -$1.23 |
Sep 2022 | N/A | N/A | $41.74 | -$1.5 |
Jun 2022 | N/A | N/A | $31.45 | -$1.72 |
Mar 2022 | N/A | N/A | $26.94 | -$1.7 |
Dec 2021 | N/A | N/A | $19.16 | -$1.6 |
Sep 2021 | N/A | N/A | $33.09 | -$1.37 |
Stock name | PE ratio | Market cap |
---|---|---|
TMDX TransMedics Group Inc | 75.44 | $3.75B |
OBIO Orchestra BioMed Holdings Inc | N/A | $117.62M |
OM Outset Medical Inc | N/A | $308.9M |
As of Jul 17, 2025, TMDX stock has a price to earnings ratio of 76.54.
TMDX's PE ratio is high because its earnings per share (EPS) is low relative to its stock price.
You can calculate the PE ratio by dividing the most recent stock price by the trailing twelve months EPS. As of today (Jul 17, 2025), TransMedics Group's stock price is $112.52. The earnings per share for the trailing twelve months (TTM) ending Mar 2025 is $1.47. Therefore, TransMedics Group's P/E ratio for today is 76.54. PE RATIO(76.54) = STOCK PRICE($112.52) / TTM EPS($1.47)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.